Cullinan Therapeutics Inc (CGEM)
15.61
-0.18
(-1.14%)
USD |
NASDAQ |
Nov 14, 10:32
Cullinan Therapeutics Market Cap: 905.01M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 915.45M |
| November 12, 2024 | 928.79M |
| November 11, 2024 | 1.001B |
| November 08, 2024 | 928.79M |
| November 07, 2024 | 903.28M |
| November 06, 2024 | 955.45M |
| November 05, 2024 | 926.47M |
| November 04, 2024 | 922.99M |
| November 01, 2024 | 914.87M |
| October 31, 2024 | 901.54M |
| October 30, 2024 | 940.38M |
| October 29, 2024 | 980.96M |
| October 28, 2024 | 936.32M |
| October 25, 2024 | 925.31M |
| October 24, 2024 | 919.51M |
| October 23, 2024 | 905.01M |
| October 22, 2024 | 924.73M |
| October 21, 2024 | 939.22M |
| October 18, 2024 | 972.27M |
| October 17, 2024 | 1.007B |
| October 16, 2024 | 1.021B |
| October 15, 2024 | 941.54M |
| October 14, 2024 | 940.96M |
| October 11, 2024 | 940.38M |
| October 10, 2024 | 920.09M |
| Date | Value |
|---|---|
| October 09, 2024 | 895.74M |
| October 08, 2024 | 934.00M |
| October 07, 2024 | 929.94M |
| October 04, 2024 | 947.34M |
| October 03, 2024 | 933.42M |
| October 02, 2024 | 956.03M |
| October 01, 2024 | 971.69M |
| September 30, 2024 | 970.53M |
| September 27, 2024 | 996.62M |
| September 26, 2024 | 1.003B |
| September 25, 2024 | 947.34M |
| September 24, 2024 | 1.023B |
| September 23, 2024 | 964.15M |
| September 20, 2024 | 1.052B |
| September 19, 2024 | 1.040B |
| September 18, 2024 | 998.94M |
| September 17, 2024 | 999.52M |
| September 16, 2024 | 981.54M |
| September 13, 2024 | 1.041B |
| September 12, 2024 | 1.022B |
| September 11, 2024 | 1.042B |
| September 10, 2024 | 1.033B |
| September 09, 2024 | 1.058B |
| September 06, 2024 | 1.042B |
| September 05, 2024 | 1.040B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
327.36M
Minimum
May 11 2022
2.325B
Maximum
Mar 10 2021
798.49M
Average
631.53M
Median
Market Cap Benchmarks
| CEL-SCI Corp | 36.29M |
| AIM ImmunoTech Inc | 15.37M |
| IGC Pharma Inc | 27.46M |
| NovaBay Pharmaceuticals Inc | 3.469M |
| Protalix BioTherapeutics Inc | 98.18M |
Market Cap Related Metrics
| Price to Book Value | 1.379 |
| Price | 15.61 |
| Earnings Yield | -19.60% |